SCHEMBL17486233

SCHEMBL17486233

CC1(C)c2ccc(-c3ccc(-c4nc(-c5ccc6c(c5)CCCC6)nc(-c5ccc6c(c5)CCCC6)n4)cn3)cc2C(C)(C)C1(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
CASP3 P42574 1/20 0.34
ATM Q13315 1/20 0.34
SENP8 Q96LD8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19295133 0.81 HSD17B1 (0.35) MEN1KMT2AHSD17B1HSD17B2
SCHEMBL17486227 0.81 HSD17B1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL17486242 0.80 GRM5 (0.35) NPC1HSD17B1HSD17B2
SCHEMBL21203022 0.80 HSD17B1 (0.31) HSD17B1HSD17B2
SCHEMBL17486244 0.80 HSD17B1 (0.40) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18015615 0.80 KDM1A (0.36) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL17485965 0.79 HSD17B1 (0.36) ALDH1A1NPC1RAB9ASMN1; SMN2ALOX15
SCHEMBL17486034 0.79 HSD17B1 (0.36) L3MBTL1HSD17B1HSD17B2
SCHEMBL17486259 0.79 HSD17B1 (0.43) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL17485991 0.79 HSD17B1 (0.43) ALDH1A1MEN1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 ALDH1A1 3721/4885NPC1 3516/4885RAB9A 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.